Executive Interview: Vectura's Ward-Lilley On Re-Focusing On The Respiratory Sector

Respiratory delivery specialist Vectura is to concentrate on developing enhanced inhaled products, as well as substitutable inhaled generics for the US market, and is pulling back from NME work. CEO James Ward-Lilley explains why.